Wolfgang Fröstl

Title: Innovations of Wolfgang Fröstl in GABAreceptor Research

Introduction

Wolfgang Fröstl is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of neuroscience through his innovative research on GABAreceptors. His work focuses on the purification and characterization of these receptors, which play a crucial role in the central and peripheral nervous systems.

Latest Patents

Wolfgang Fröstl holds 1 patent related to his research. The patent provides purified GABAreceptors and receptor proteins derived from rat and human sources, as well as nucleic acids encoding such proteins. The invention includes methods for isolating other members of the GABAreceptor family using DNA cloning technology and probes derived from the disclosed sequences. Furthermore, it relates to the use of GABAreceptors and receptor proteins in identifying and characterizing compounds that modulate their activity, which may be useful as pharmacological agents for treating various disorders.

Career Highlights

Fröstl is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to advancements in drug discovery and development, particularly in the area of neurological disorders. His research has implications for understanding and treating conditions associated with the nervous system.

Collaborations

Wolfgang Fröstl has collaborated with esteemed colleagues such as Klemens Kaupmann and Bernhard Bettler. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field of GABAreceptor biology.

Conclusion

Wolfgang Fröstl's innovative work on GABAreceptors has the potential to impact pharmacological treatments for neurological disorders. His contributions to the field highlight the importance of research in understanding complex biological systems.